glp 1 agonist addiction How GLP-1 Can Help in Treating Disorders? GLP-1 Receptor Agonists in Addiction

Long interested in Holst's work, in 1990 Novo Nordisk recruited his colleague Schwartz to develop small molecules able to activate the GLP receptor in the pancreas (Molteni, Chen)

Pi-Sunyer X, et al

Endogenous GLP-1 has a half-life of 2 minutes, as dipeptidyl peptidase enzymes rapidly inactivate incretin hormones

It is one of the factors that could affect the FDAs review timeline

J Diabetes Investig 1:823 Samms RJ, Coghlan MP, Sloop KW (2020) How may gip enhance the therapeutic efficacy of GLP-1

Conclusion The convergence of pharmacological innovation, digital health strategies, and equitable care initiatives is expected to revolutionize obesity therapeutics in the coming decade